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Endocrine and Metabolic 
Pathways Linked to Keratoconus: 
Implications for the Role of 
Hormones in the Stromal 
Microenvironment
Tina B McKay1, Jesper Hjortdal2, Henrik Sejersen2, John M Asara3, Jennifer Wu4 & 
Dimitrios Karamichos1,4
Hormones play a critical role in regulating tissue function by promoting cell survival, proliferation, 
and differentiation. Our study explores the influence of endocrine function in regulating metabolism 
and inflammatory pathways in Keratoconus (KC), which is a corneal thinning disease associated with 
reduced stromal deposition. KC is known to be a multifactorial disease with an elusive pathogenesis. 
We utilized a cross-sectional study analyzing clinical features and saliva samples from sixty-four KC 
patients and fourteen healthy controls. In order to determine if endocrine function varied between 
healthy controls and KC, we measured hormone levels in saliva and found significantly increased 
dehydroepiandrosterone sulfate (DHEA-S) and reduced estrone levels in KC patients compared to 
healthy controls. We measured significant variations in metabolites associated with pro-inflammatory 
processes, including myoinositol and 1-methyl-histidine, by targeted mass spectrometry. We also 
measured significantly increased IL-16 and stem cell factor in KC saliva samples compared to healthy 
controls, with higher expression of these pro-inflammatory proteins correlating with increased KC 
clinical grade, corneal curvature, and stromal thinning. Our results identify a novel mechanism linking 
KC and pro-inflammatory markers and suggest that altered hormone levels modulate metabolism, 
cytokine, and growth factor expression leading to increased severity of the KC condition.
Hormone production occurs in the major endocrine and exocrine organ systems in the human body, including 
the pituitary gland, thymus, pineal gland, thyroid, pancreas, ovaries, testes, adrenal glands, salivary glands, and 
sweat glands1. Endocrine secretions are released directly into the bloodstream where they circulate to organs and 
tissues via the lymphatic and blood vasculature. Hormones have been reported to play a significant role in various 
pathologies, including autoimmune disorders2,3 and cancer4. The gender-dependence of many of these diseases is 
correlated with variations in sex hormones, such as estrogen and testosterone5. These steroid-based hormones are 
synthesized in the smooth endoplasmic reticulum or mitochondria from precursors that are secreted systemically. 
Dehydroepiandrosterone sulfate (DHEA-S) is a common precursor to other androgens including androstene-
diol, androstenedione, testosterone, and dihydrotestosterone, which are generated following the conversion of 
DHEA-S to dehydroepiandrosterone (DHEA) in a tissue-dependent manner6. Studies have shown that DHEA-S 
levels do not vary with gender but are significantly reduced with aging7. Supplementation with DHEA-S has been 
studied clinically to determine its effects in improving cognitive function, depression, and fatigue8,9. Furthermore, 
DHEA-S has been shown to modulate patient outcome in inflammatory diseases, such as Lupus10 and Sjögren’s 
syndrome11, with females composing 88% and 94% of the patient population, respectively12. Hormones are also 
known to have profound effects on regulating lacrimal gland function and dry eye development13. Androgen and 
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estrogen receptors have been identified in the human cornea14 and retina15 suggesting that hormones regulate 
tissue function within the anterior and posterior segments of the eye as well.
The most common corneal dystrophy in the US is Keratoconus (KC), which is a corneal thinning disease 
that affects over 1 in 2000 people worldwide and results in corneal ectasia and significantly impaired vision16,17. 
Though not considered an overt inflammatory disorder due to the lack of clinical signs, KC has been associ-
ated with upregulated pro-inflammatory cytokines, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α ), and 
matrix metalloprotease-9 (MMP-9), isolated in tears from KC patients18,19. Furthermore, eye rubbing due to ocu-
lar irritation is the most common etiological feature occurring in over two-thirds of KC patients20,21. These studies 
suggest that an inflammatory response may play an important role in the progression of KC leading to thinning 
of the stroma.
Normal corneal stromal structure is assembled and maintained at an average thickness of roughly 532–610 nm 
varying from person to person22,23. In the KC cornea, the central corneal thickness is reduced 8–30% with aver-
ages reported of 447.8 μ m (± 57.8)24. Even slight thinning of the corneal stroma can lead to a bulging phenome-
non that distorts transmission of light to the retina. In KC the eye becomes cone-like at the region with increased 
thinning near the corneal apex in the presence of normal intraocular pressure that is maintained by fluid flux. 
Variations in hormone levels have been shown to have direct effects on corneal thickness in healthy individuals25. 
Reports have been published as to the gender differences within the KC population26–28. However, to the authors’ 
knowledge, investigation into alterations in hormone levels in KC has not been explored. The purpose of our 
study was to elucidate the role of hormones and inflammation in the KC pathology by addressing the following 
questions: Is there a correlation between KC severity and hormone levels?, 2) Is systemic metabolism altered in 
KC that may drive a pro-inflammatory response?, and 3) Which cytokines or growth factors are elevated in KC 
leading to a more severe clinical presentation? In order to do so, we utilized a non-invasive method that has never 
been used before for the diagnosis or treatment of KC. Saliva screening together with clinical observations was 
used here to determine its correlation to KC.
The long-term goal of these studies is to identify biomarkers that contribute or drive KC pathogenesis in 
order to assist in early diagnosis and enable development of therapeutics to treat this visually debilitating disease. 
Previous studies have identified inflammatory markers in KC18,19, however, to the authors’ knowledge, no studies 
have investigated systemic inflammation and KC severity. Based on the early age of onset29 and gender domi-
nance26–28 of KC, we hypothesized that altered hormone levels may play a role in KC development, with inflam-
matory factors contributing to a more severe disease phenotype. This impactful work explores how systemic 
changes in hormone levels can contribute to stromal deposition defects seen in KC.
Results
KC Patient Demographics. In a total of 64 KC patients, 44 (69%) were identified as male and 20 (31%) were 
identified as female (Fig. 1A). Since KC leads to significant defects in visual acuity, most patients are prescribed 
glasses or contact lenses to correct vision30. We classified the distribution of KC patients based on treatment for 
correction for visual acuity deficits due to KC in both genders (Fig. 1B). The distribution of subgroups based on 
prescribed treatment modality within the KC male population including, no treatment (36%), glasses (39%), and 
contact lenses (25%) did not vary between treatments (Fig. 1B). However, within KC female patients, contact lens 
wearers (65%) were considerably higher compared to the glasses-prescribed subgroup (25%) or no treatment 
(10%) suggesting a correlation between gender and favored treatment modality (Fig. 1B). The KC population also 
showed a significant increase in average age (> 8 years) in the females with KC at 34 ± 1.75 years old compared to 
their male counterparts (26 ± 1.14 years) (Fig. 1C, p = 0.0002). The KC population in our study was male-domi-
nated with increased age of female KC patients. A significant reduction in central corneal thickness (CCtmin) and 
increased maximum corneal curvature (Kmax) are indicative of KC diagnosis and are often proportional to KC 
severity or grade. In order to determine if either gender correlated with differential severity of disease, we ana-
lyzed KC grade, CCtmin, and Kmax based on gender (Fig. 1D–F). No statistical difference was observed between 
gender and severity suggesting that though KC is male-dominated, gender does not directly modulate KC sever-
ity (Fig. 1D–F). Further analysis of clinical features (KC grade, Kmax, CCtmin) and treatment for visual acuity 
(no treatment, glasses, contact lenses) showed no statistical variations between treatment modality and severity 
of KC (Supplemental Fig. S1A,B). However, a subpopulation of the contact lens wearers had substantially higher 
corneal curvature (Kmax) values compared to the mean of the population (Supplemental Fig. S1C). Contact 
lenses may contribute to KC progression by promoting local hypoxia within the central cornea31.
Altered hormone levels in KC. Systemic changes in estrogen and androgen levels have been shown to 
directly modulate corneal thickness during pregnancy and development25,32,33. Surprisingly, to-date, no studies 
have reported their link in KC. In order to determine the role of hormones in KC we quantified concentrations 
of estrone, estriol, 17β -estradiol, and DHEA-S found in saliva samples (Fig. 2). Our results showed a significant 
reduction in estrone (1.3-fold, p = 0.0222) levels in KC saliva samples compared to healthy controls (Fig. 2A) 
with no significant differences in estriol or 17β -estradiol levels (Fig. 2B,C). DHEA-S levels were significantly 
higher (2.5-fold, p = 0.0359) in KC samples compared to controls (Fig. 2D). Analysis of hormone levels based 
on gender was used in order to determine the differences within HC and KC groups. As expected, we found 
a female-dependent elevation of estrone in both the healthy controls and KC patients compared to their male 
counterparts (Fig. 2E, 1.6-fold and 1-fold, respectively, p ≤ 0.038). Furthermore, estrone levels were reduced 
in KC female patients compared to the healthy female controls. The estrogen-derived hormones, estriol and 
17β -estradiol, were not dependent on gender in our population and slight reduction was seen in KC patient sam-
ples from both genders compared to controls (Fig. 2F,G). Our results show that both male and female KC patients 
had increased DHEA-S levels (1.8-fold, p = 0.047) compared to the healthy controls supporting a role for elevated 
DHEA-S and reduced estrone in KC pathogenesis (Fig. 2H). Our data shows that there were significant variations 
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in estrone and DHEA-S in the female and male KC population, respectively, which attribute to altered endocrine 
activity and KC. In order to determine if the systemic concentration of one hormone modulated that of another, 
we plotted ratios of hormone levels for KC patients compared to healthy controls. We measured a robust linear 
response between estrone and estriol levels in both groups (Supplemental Fig. S2), even though the mean estrone 
levels in KC patients were significantly lower than healthy controls (Fig. 2). Moreover, the increased DHEA-S 
levels did not correlate with increased estrone, estriol, or 17β -estradiol suggesting that systemic levels of estrogens 
are independent of DHEA-S production, and therefore increased DHEA-S levels may have a tissue-dependent 
response within the cornea that may contribute to the KC pathology.
Hormone Levels and KC Severity. In order to determine if varying degrees of severity of KC can be cor-
related with altered hormone levels, we analyzed estrone, estriol, 17β -estradiol, and DHEA-S levels relative to 
age, KC grade, maximum curvature (Kmax), and minimum central corneal thickness (CCtmin) (Fig. 3). Both 
estrone and estriol levels were linear with a slight reduction with increases in age in both healthy controls and KC 
patients (Fig. 3A,E). Neither KC grade, Kmax, or CCtmin correlated with estrone or estriol levels (Fig. 3B–D, F–H). 
17β -estradiol levels were more variable with age in KC patients with slightly lower levels in KC grades greater 
than 2, high Kmax (> 50), and thin central corneal thickness (< 425 microns) (Fig. 3I–L). DHEA-S levels also 
gave a linear reduction with age in KC patients with no correlation with KC grade, Kmax, or central corneal 
thickness (Fig. 3M–P). These results suggest that a complex interplay exists between hormonal levels and severity 
of KC with altered endocrine function modulating other factors, such as metabolism or inflammation.
Role of Metabolism in KC. KC has been reported to have significant differences in cellular metabolism 
within corneal stromal cells that may give rise to increased oxidative stress and bioenergetics34,35. We have pre-
viously identified a significant reduction in adenosine triphosphate (ATP) production via oxidative phospho-
rylation and an increase in aerobic glycolysis favoring lactate production in primary cells isolated from KC 
patients35. Elevated lactate levels are associated with hypoxic conditions with a lowering of the extracellular pH 
and increased oxidative stress and apoptosis36, which are both associated with KC34,35,37,38. In order to deter-
mine if systemic changes in metabolism contribute to KC development, we quantified the concentrations of 
metabolites (Supplemental Fig. S4) found within saliva using shot-gun tandem mass spectrometry39 and found 
significant variations in metabolite flux suggesting a potential link to altered systemic metabolism and KC. As 
shown in the heat map (Fig. 4), the most dominant metabolites present within human saliva from both healthy 
and KC individuals were uric acid, citrate, betaine, and proline (Fig. 4). Furthermore, the greatest variations in 
metabolite flux between KC and healthy controls were linked to glucose metabolism. In order to determine if 
altered glucose-derived metabolite levels led to variations in metabolic flux in other pathways, we determined 
the salivary profile of metabolites derived from the four major classes of biomolecules: nucleic acid, saccharide, 
Figure 1. Demographics of the Keratoconus (KC) population based on gender. (A) In a total of 64 patients, 
44 (69%) were identified as male with 20 (31%) were identified as female suggesting increased male dominance 
in the KC population. (B) Distribution of KC patients based on treatment for correction for visual acuity deficits 
due to KC in male KC patients. (C) Average age of KC patients divided by gender. Gender correlations with 
(D) severity of KC as clinically diagnosed as KC grade, (E) measure of central corneal curvature (Kmax), and 
(F) minimum central corneal thickness (CCtmin). Statistical significance was measured using a Mann-Whitney 
two-tailed T-test with p ≤ 0.05 considered statistically significant. Error bars represent standard error of the 
mean. n = 64 total patients, with the clinical parameters for each KC eye tabulated in (D–F), total number of 
eyes ≥ 110.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:25534 | DOI: 10.1038/srep25534
lipid, and protein (Fig. 5). We measured significant variations in adenosine monophosphate (AMP) (12.7-fold), 
D-gluconate (12.3-fold), and hexose-phosphate (3.9-fold) in KC saliva samples suggesting variations in nucleic 
acid and glucose metabolism (Fig. 5C,E,F, p = 0.0286). Lipid-derived metabolites, including cholesterol, cho-
lesteryl sulfate, glycerate, and geranyl-pyrophosphate (PP), did not vary between healthy controls and KC samples 
(Fig. 5I–L). Moreover, protein metabolism was also not altered in the disease samples suggesting that hormonal 
differences in KC primarily modulate glucose metabolism independent of lipid- or protein-breakdown.
Since our results suggested that glucose metabolism was altered in the KC pathology, we investigated the 
conversion of glucose to lactate or pyruvate in order to determine if oxidative phosphorylation was modu-
lated (Supplemental Fig. S3A–C). We found substantial increases in lactate:malate (5-fold, p = 0.0951) and 
lactate:pyruvate (4-fold, p = 0.0659) in KC saliva samples suggesting that glucose is converted to the anaero-
bic glycolytic product, lactate, rather than proceeding through the more efficient mode to generate adenosine 
triphosphate (ATP) via the citric acid cycle and oxidative phosphorylation. Altered cellular metabolism can 
contribute to increased intracellular oxidative stress with glutathione as the primary antioxidant responsible for 
reducing reactive oxygen species. Since KC has been correlated with increased oxidative stress within the cor-
nea34,35,40 and in vitro by our group35, we measured salivary concentrations of reduced (GSH) and oxidized glu-
tathione (GSSG) levels in order to determine if systemic GSH levels are affected in KC (Supplemental Fig. 3D,E). 
We measured a significant reduction in GSH (p = 0.0384) and a slight reduction in GSH:GSSG (p = 0.1055) in 
KC saliva samples compared to healthy controls suggesting systemic elevated oxidative stress may be important 
in KC (Supplemental Fig. 3D–F).
Systemic pro-inflammatory markers and cytokines in KC. Estrogens have been shown to directly 
modulate expression of pro-inflammatory cytokines, including IL-6 and TNF-α , within corneal epithelial cells41. 
Myoinositol and 1-methyl-histidine are metabolites that have been associated with pro-inflammatory responses 
in vivo42. Since estrone and DHEA-S levels were altered in our KC samples, we sought to determine if the differ-
ences in hormone levels contribute to a pro-inflammatory response. We measured significant increase of myo-
inositol (1.6-fold, p = 0.0286) and 1-methyl-histidine (6.2-fold, p = 0.0286) in KC samples with no difference in 
histidine levels (Fig. 6, p = 0.1143).
In order to determine if systemic changes in pro-inflammatory cytokines and growth factors occurred in KC, 
we utilized a microarray capable of probing for 80 proteins present in saliva. The highest abundance of cytokines 
and growth factors secreted in human saliva were epidermal growth factor (EGF), interleukin-8 (IL-8), GRO or 
chemokine (C-X-C motif) ligand 1 (CXCL1), and epithelial-derived neutrophil-activating peptide-78 (ENA-78) 
(Fig. 7). Interestingly, we measured significantly increased stem cell factor (SCF) (1.9-fold, p = 0.0427) and 
interleukin-16 (IL-16) (p = 2.1-fold, 0.0137) in KC saliva samples compared to healthy controls (Fig. 7B). SCF is 
an important growth factor that is critical for promoting differentiation of different cell types, including progeni-
tor cells to myeloid and erythroid-derived cells43. SCF functions as a ligand for the c-Kit tyrosine kinase receptor 
(c-Kit), which is important in propagating pro-survival signals to induce proliferation and differentiation43,44. Our 
Figure 2. Salivary hormone levels measured in healthy controls (HC) and Keratoconus (KC) patients.  
(A) Estrone, (B) estriol, (C) 17β -estradiol, and (D) dehydroepiandrosterone-sulfate (DHEA-S) levels measured 
by enzyme-linked immunosorbent assay (ELISA). A significant reduction in estrone levels were measured in 
KC with increased DHEA-S levels and no variations in estriol and 17β -estradiol levels between HC and KC. 
(E–H) Breakdown of hormone levels based on gender. Statistical significance was determined using a Mann-
Whitney two-tailed T-test with p ≤ 0.05 considered statistically significant. Error bars represent standard error 
of the mean. n ≥ 6 for all samples, with each n representing a different patient. All patient samples were analyzed 
for each hormone present, and only samples with concentrations within the range of the standard curve were 
plotted.
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results suggest that SCF plays a role in KC and potentially provides a link between pro-inflammatory processes 
and KC pathobiology.
Furthermore, we analyzed these three elevated systemic pro-inflammatory molecules relative to KC severity, 
as measured by clinical standards. We quantified KC severity (KC grade) versus expression of IL-8, IL-16, and 
SCF. We found a slight linear response with increasing KC grade and IL-8 levels, but without any correlation 
with Kmax and an increase in corneal thickness with the highest IL-8 concentration (Fig. 8D–F). Elevated IL-16 
levels correlated with more severe KC features with increased KC grade, maximum curvature, and a slight reduc-
tion in corneal thickness (Fig. 8G–I). IL-16 is a lymphotactic factor able to recruit activated T cells and other 
CD4-expressing cells. It appeared that increased SCF levels exhibited the highest linearity with severity of disease, 
with elevated SCF expression correlating with higher KC grade, maximum curvature, and thinner corneal stroma 
(Fig. 8J–L). This data suggests that a systemic inflammatory process, involving IL-16 and SCF, may contribute to 
increased KC severity and reveals a novel connection between elevated hormonal levels and inflammation in KC.
Discussion
Regulation of hormone levels occurs throughout development, from birth to adolescence, puberty to adult-
hood, and then postmenopausal to the elderly45–49. These stages of development are correlated with significant 
variations in levels of DHEA-S and estrogens with climatic increases into puberty and gradual reductions with 
aging7,50,51. KC is a corneal-thinning disease that is primarily diagnosed from post-pubescence to adulthood, 
Figure 3. Hormone levels relative to clinical presentation characterized by KC grade, central corneal 
thickness (CCtmin), maximum curvature (Kmax), and in Keratoconus (KC) patients compared to healthy 
controls (HC). (A–D) Estrone, (E–H) estriol, (I–L) 17β -estradiol, and (M–P) DHEA-S levels plotted relative 
to age at time of collection, clinical severity (KC grade), maximum curvature (Kmax), and minimum central 
corneal thickness (CCtmin) measured in microns. For each patient, the eye with the most severe KC clinical 
features was plotted versus hormone concentration. (A,E,I,M) Best-fit linear curve for age-dependence of 
hormone concentrations shown with solid lines and the 90% confidence interval with dotted lines (HC in blue 
and KC in red).
www.nature.com/scientificreports/
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Figure 4. Heat map of metabolites isolated in saliva from healthy controls (HC) and Keratoconus (KC) 
patients isolated by LC-MS/MS. Metabolites present at high concentrations are depicted in red with moderate 
concentrations shown in black, and low metabolites in blue. n = 4 for each group, with each n representing a 
different patient.
www.nature.com/scientificreports/
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Figure 5. Salivary profile of the major classes of biomolecules measured in healthy controls (HC) and 
Keratoconus (KC) patients. (A–D) Nucleic acid-derived, (E–H) saccharide-derived, (I–L) lipid-derived, and 
(M–P) protein-derived metabolites were measured by LC/MS-MS. Significantly elevated AMP and D-glucono-
lactone-6-phosphate were measured in KC saliva samples compared to HCs. n = 4, with each n representing a 
different patient. The boxplot representation depicts the central rectangle spanning the interquartile range with 
a line showing the median. Whiskers above and below the central box represent the maximum and minimum 
data points, respectively. Statistical analysis was performed using a Mann-Whitney two-tailed T-test with 
p ≤ 0.05 considered statistically significant.
Figure 6. Pro-inflammatory biomarkers isolated in saliva from healthy controls (HC) and Keratoconus 
(KC) patients by LC/MS-MS. Myoinositol and histidine-derivatives have been associated with inflammation. 
(A–C) Myoinositol and 1-methyl-histidine salivary levels were significantly higher in KC patients with no 
significant variation in histidine. n = 4 for all data, with each n representing a different patient. The boxplot 
representation depicts the central rectangle spanning the interquartile range with a line showing the median. 
Whiskers above and below the central box represent the maximum and minimum data points, respectively. 
Statistical significance was determined using a Mann-Whitney two-tailed T-test with p ≤ 0.05 considered 
statistically significant.
www.nature.com/scientificreports/
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with our study showing an average age of 26 (± 1.14) years old in males and 34 (± 1.75) years old in females. It is 
known that KC progression often stabilizes at middle age16 with a younger onset of disease associated with a more 
severe disease condition requiring penetrating keratoplasty52. The factors that contribute to stabilization of the 
disease are unknown. Our results suggest that hormonal regulation may play a central role in the KC pathology. 
We found significant increases in salivary DHEA-S levels and reduced estrone levels in KC patients independent 
of gender. No apparent correlation between hormone concentration and increased severity of KC was detected, 
which led us to suspect that perhaps hormone levels modulate other systemic factors that may affect the stromal 
microenvironment, such as inflammatory factors and cellular metabolism, which might promote KC progression.
Elevated DHEA levels have been found to increase immune function by blocking endogenous glucocorticoid 
activity53,54. Our results showed elevated DHEA-S levels correlated with increased IL-16 and SCF, with higher 
IL-16 and SCF corresponding to increased KC severity. IL-16 has been found to be elevated along with other 
cytokines in the vitreous of pseudophakic eyes following cataract surgery55 and is known to play a complex func-
tional role in the regulation of the immune response through interaction with T cells and dendritic cells56. SCF 
has a much different role in immune regulation as a ligand for the tyrosine receptor, c-kit, and is involved in 
promoting differentiation of lymphoid, myeloid, erythroid, and megakaryocytic cell lineages57. Upregulation of 
both IL-16 and SCF suggest an important role for the immune system and cell differentiation patterns in the KC 
pathobiology. Interestingly, we did not observe significant upregulation of other pro-inflammatory cytokines 
suggesting that IL-16 and SCF are specific factors that may contribute to KC severity. Systemic metabolic features 
of KC corresponded with the upregulation of myoinositol and 1-methyl-histidine as potential biomarkers in 
agreement with the presence of systemic pro-inflammatory factors.
KC severity is characterized by the clinical grade, maximum curvature, and minimum corneal thickness. 
Corneal thickness is a measure of extracellular matrix deposition in the cornea with gradual thinning of the 
stroma leading to KC development. We identified a direct link between elevated IL-16 and SCF and thinner KC 
corneas, increased curvature, and KC grade suggesting elevated inflammatory factors may contribute to disease 
severity. We have previously identified KC as a metabolically-driven disease in primary corneal stromal cells 
derived from KC patients with increased oxidative stress and reduced matrix thickness35,58. Our current study, for 
the first time to the authors’ knowledge, utilizes human saliva samples to correlate clinical findings with metabolic 
changes in KC. Our results suggest that KC is at least partially a systemic disease driven by altered hormones 
contributing to stromal thinning in the KC cornea. Further studies are clearly needed with the participation of 
larger number of KC patients. This work represents a significant step in assisting with KC prognosis and drug 
development.
Methods
Study Design. A cross-sectional, controlled laboratory experimental study was conducted from clinical data 
and saliva samples collected from KC patients and healthy controls. Given that KC has a prevalence of 1:200016, 
our study attempted to isolate the maximum number of saliva samples from two centers (Aarhus University 
Hospital, Denmark and Dean McGee Eye Institute, USA). Inclusion/exclusion criteria for data collection were 
established at the onset of data analysis to exclude clinical data from patients who had previously received collagen 
Figure 7. Relative amounts of 80 cytokines and growth factors present in human saliva isolated from 
healthy controls (HC) and Keratoconus (KC) patients measured using a microarray. (A) Representative 
microarray membranes. (B) Quantification of all cytokines and growth factors detected on the microarray. Data 
normalized to the positive control bands present on each membrane. Statistical significance was determined 
using the Holm-Sidak method in a T-test, with alpha = 5.00%. n = 7 for HC and n = 9 for KC. Y-axis was set to 
0, which cut off negative values. Error bars represent standard error of the mean.
www.nature.com/scientificreports/
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crosslinking or undergone penetrating keratoplasty. Robust regression and Outlier removal (ROUT) was utilized 
to determine outliers post-hoc, as previously described59. Not all saliva samples yielded values within the standard 
curve and were therefore excluded from analysis. Replicates varied between experiments and are defined in the 
appropriate figure legends. Sample replicates were analyzed and screened individually with no pooling of samples.
Ethics and Inclusion Criteria. The ethics committee of both the University of Oklahoma and the Central 
Denmark Region approved all experimental protocols reported in this study. IRB approvals (#3450 and #1-10-
72-77-14) were obtained by both ethic committees and written informed consent was received from participants 
prior to inclusion in the study. Demographics data (age, gender, CCtmin, Kmax, KC grade) was provided by a cli-
nician with no identifiers linked to clinical information. This study met the tenets of the Declaration of Helsinki. 
Inclusion criteria for healthy controls required absence of KC diagnosis or other corneal diseases. Inclusion crite-
ria for KC patients required diagnosis of KC by a certified ophthalmologist and absence of other ophthalmic con-
ditions. Healthy controls and KC patients were age-matched as closely as possible with average ages of 35 ± 3.138 
and 29 ± 1.064 years, respectively (p = 0.0896, Supplemental Fig. S7A). Kmax and CCtmin values for controls were 
only available for n = 8 patients and are reported in Supplemental Fig. S7B,C.
Figure 8. Pro-inflammatory cytokines and growth factors, IL-8, IL-16, and stem cell factor (SCF) 
correlated with hormone levels and KC severity. (A) IL-8, (B) IL-16, and (C) SCF expression plotted relative to 
DHEA-S levels. IL-8, IL-16, and SCF expression relative to (D–F) KC grade, (G–I) Maximum corneal curvature 
(Kmax), (J–L) Minimum central corneal thickness (CCtmin) measured in microns. Best-fit linear line plotted 
with 90% confidence intervals (dotted lines). Expression of IL-8, IL-16, and SCF measured using densitometry 
from a microarray. n = 7 for HC and n = 9 for KC. Clinical features (Kmax, and CCtmin) were not collected for 
all HC and therefore were excluded from (D–L).
www.nature.com/scientificreports/
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Saliva Collection. Patients were requested to rinse mouth with water prior to sample collection. Saliva sam-
ples (~2mL) were collected in plastic tubes by passive droll and frozen immediately60. Prior to processing, saliva 
samples were aliquoted and stored at < 80 °C until further use.
Salivary ELISAs. The following commercial immunoassay kits were used to detect hormone levels present 
in saliva: salivary estrone enzyme immunoassay kit (1–3202), salivary estriol/HS estriol enzyme immunoassay 
kit (1–1802), high sensitivity salivary 17β -estradiol enzyme immunoassay kit (1–3702), salivary DHEA-S enzyme 
immunoassay kit (1–1252) (Salimetrics, State College, PA). Briefly, saliva samples were maintained on ice and 
centrifuged at 3000 rpm (4 °C) for 15 minutes to pellet debris and mucins. 100 μ L of neat saliva, standard, or 
control and the re-constituted conjugate was added to the appropriate well and incubated for 1 hour at room tem-
perature or overnight at 4 °C with rocking. Wells were then washed 4× with provided wash buffer and incubated 
with the TMB solution for 30 minutes covered and at room temperature. The stop solution was then added, mixed 
briefly, and read in a plate reader at 450 nm. A 4-parameter non-linear regression curve fit was used to calculate 
the concentrations of controls and unknowns extrapolated from the standard curve.
Salivary Metabolite Isolation. Metabolites were isolated as previously described35. Collected saliva sam-
ples were centrifuged at 3000 rpm (4 °C) for 15 minutes to pellet debris and mucins. 500 μ L of the supernatant 
were added to 4 mL of cold 80% methanol and incubated on dry ice for 15 minutes. Samples were then centrifuged 
and metabolites isolated (repeated 3× ), dried using a speedVac, and stored at − 80 °C until further use.
Mass Spectrometry Processing. Isolated metabolites were dissolved in 5 μ L of HPLC-pure water and 
injected into a hybrid 5500 QTRAP triple quadrupole mass spectrometer (AB/SCIEX) coupled to a Prominence 
UFLC system (Shimadzu) using an Amide HILIC column (Waters) and analyzed with selected reaction moni-
toring (SRM) with positive/negative polarity switching. Peak areas from the total ion current were quantified for 
297 metabolites39. Only metabolites that were expressed in n ≥ 3 samples were considered for further analysis. 
CIMminer software available from the genomics and bioinformatics group (http://discover.nci.nih.gov/cim-
miner/home.do) was used to generate the heat map following input of raw net intensity data for all metabolites 
with n ≥ 3 samples and clustering according to abundance.
Human Cytokine Antibody Array. Manufacturer’s protocol was followed for the cytokine microarray 
(ab133998, Abcam, Cambridge, MA). Briefly, saliva sample was centrifuged at 3000 rpm (4 °C) for 15 minutes 
to pellet debris and mucins. Following blocking of the membrane, 1 mL of supernatant (neat) was incubated 
with the membrane overnight at 4 °C with rocking. Following washing, reconstituted 1× Biotin-Conjugated 
Anti-Cytokines was incubated with membrane for 2 hours at room temperature followed by washing. 1× 
HRP-Conjugated Streptavidin was then incubated with membrane for 2 hours at room temperature. Detection 
buffer C and D were added to the washed membrane and immediately imaged. Densitometry measurements 
were performed and background intensity was subtracted from the raw net intensity. In order to compare values 
between microarrays, all values were normalized to the average intensity of the positive control wells (1–4) on the 
same membrane. Values for each probe were then averaged and plotted.
Statistical Analysis. Statistical analysis was performed using Graph Pad Prism 6 and a Mann-Whitney 
unpaired T-test or Holm-Sidak method in a T-test were used to determine significance. A p-value < 0.05 was 
considered statistically significant.
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